Papadimitriou, C A <br/><br/>
Paclitaxel, cisplatin, and epirubicin first-line chemotherapy in stage III and IV ovarian carcinoma: long-term results of a phase II study.  [electronic resource] 

 -  Cancer  Oct 2000 
 - 1547-54 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article 
<br/><br/><label>ISSN: </label>0008-543X 
<br/><br/><label>Standard No.: </label>10.1002/1097-0142(20001001)89:7<1547::aid-cncr19>3.0.co;2-p  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Cisplatin--administration & dosage<br/>Drug Administration Schedule<br/>Epirubicin--administration & dosage<br/>Female<br/>Granulocyte Colony-Stimulating Factor--administration & dosage<br/>Humans<br/>Infusions, Intravenous<br/>Middle Aged<br/>Ovarian Neoplasms--drug therapy<br/>Paclitaxel--administration & dosage<br/>Treatment Outcome